Laddar...
SUN-178 A Not So "Sweet" DKA: A Case of Euglycemic Diabetic Ketoacidosis Caused by Dapagliflozin/Liraglutide Combination
Background: Combined use of Glucagon-like peptide-1 receptor agonists (GLP-1RA) & sodium-glucose cotransporter 2 inhibitors (SGLT2i) may provide particular advantages for treating type 2 diabetes mellitus (DM2). Both promote weight loss and have favorable effects on cardiovascular outcomes while...
Sparad:
| I publikationen: | J Endocr Soc |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Endocrine Society
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553086/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SUN-178 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|